A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED, PHASE III STUDY FOR REDUCING DEPENDENCY AND CARDIOVASCULAR EVENTS WITH ORAL COLCHICINE 0.5MG ONCE DAILY COMPARED WITH PLACEBO IN PARTICIPANTS WITH SPONTANEOUS INTRACEREBRAL HEMORRHAGE AND ESTABLISHED, OR RISK FACTORS FOR, ATHEROSCLEROSIS

Registry ID

NCT06587737 (COVASC-ICH 2)

Source registry

HEALTH_CANADA

Status

Pending

Phase

PHASE3

Study type

INTERVENTIONAL

Sponsor

HAMILTON HEALTH SCIENCES CORPORATION

Last update

2024-10-22

Conditions

• INTRACEREBAL HEMORRAGE

Related clinical trials

• EDOXABAN FOR INTRACRANIAL HEMORRHAGE SURVIVORS WITH ATRIAL FIBRILLATION
• NON-VITAMIN K ANTAGONIST ORAL ANTICOAGULANTS FOR STROKE PREVENTION IN PATIENTS WITH ATRIAL FIBRILLATION AND PREVIOUS INTRACEREBRAL HEMORRHAGE STUDY
• A PHASE 1B MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY AND TOLERABILITY AND DETERMINE THE MAXIMUM TOLERATED DOSE OF PF-05230907 IN SUBJECTS WITH INTRACEREBRAL HEMORRHAGE (ICH)
• MINIMALLY INVASIVE SURGERY PLUS RT-PA FOR ICH EVACUATION MISTIE

View on source registry